Michał Tarnowski

Steroidal mineralocorticoid receptor antagonist use and all-cause mortality in patients with heart failure: insights from the HEROES study

Iwona Gorczyca−Michta, Michał Tarnowski, Anna Furman-Niedziejko, Agnieszka Karolina Major et autres

Introduction not needed Material and methods not needed Results not needed Conclusions not needed

pl, in (code pays fourni par la source)

Association Between Heart Failure Etiology and All-Cause Mortality with Sex-Specific Considerations: Insights from the HEROES Registry

Michał Tarnowski, Robert Morawiec, Agata Anna Galas, Agata Tymińska et autres

Background: Heart failure (HF) is a complex clinical syndrome, and its prognosis depends on many factors, including its etiology and the patient’s sex. We aimed to perform gendered evaluations on ischemic etiology’s impact on HF prognosis. Methods: Hospitalized patients and outpatients were …

in, pl (code pays fourni par la source)

Etiology of heart failure across the ejection fraction spectrum and association with mortality – insight from the HEart failuRe ObsErvational study (HEROES)

Michał Tarnowski, Karolina Molenda, Robert Morawiec, Agata Galas et autres

in, pl (code pays fourni par la source)

Levosimendan: a general overview

Michał Tarnowski, Martyna Wałcerz-Bajorska, Paulina Brania, Dominik Domoń et autres

Heart failure remains a major clinical and public health problem worldwide, associated with high morbidity and mortality, and frequent hospitalizations. Despite advances in pharmacological and device-based therapies, management of acute and advanced heart failure remains challenging, particularly in patients requiring inotropic support. …

in, pl (code pays fourni par la source)

From Childhood to Old Age: Current Knowledge and Practical Approaches to Metabolic Dysfunction-Associated Steatotic Liver Disease

Iwona Gorczyca-Głowacka, Michał Tarnowski, Anna Zmelonek-Znamirowska, Przemysław Wolak

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is one of the most common chronic liver diseases across all age groups. Methods: This review synthesizes the current evidence from landmark studies on the risk factors, diagnosis, and management of MASLD in pediatric, adult, …

pl, in (code pays fourni par la source)

Macroscopic evidence of a platelet-rich thrombus in a diabetic patient with non-ST-elevation myocardial infarction

Paulina Brania, Kinga Furtak, Michał Tarnowski, Dominik Domoń et autres

in, pl (code pays fourni par la source)

Sex-related differences in long-term outcomes of drug-coated balloons versus thin-strut drug-eluting stents in the treatment of in-stent restenosis (DCB-DRAGON Registry)

Rafał Januszek, Michał Tarnowski, Paweł Pawlus, Sylwia Iwanczyk et autres

Introduction: Drug-coated balloons (DCB) and drug-eluting stents (DES) are established options for coronary in-stent restenosis (ISR); evidence on sex-specific outcomes remains limited. Rafał Januszek et al. Sex-related differences in long-term outcomes of drug-coated balloons versus thin-strut drug-eluting stents in the treatment of …

in, pl, it (code pays fourni par la source)

Periprocedural management of patients with hereditary angioedema undergoing coronary angiography and percutaneous coronary intervention

Michał Tarnowski, Paulina Brania, Iwona Gorczyca-Głowacka, Zbigniew Siudak

Hereditary angioedema (HAE) is a rare, potentially life-threatening genetic disorder caused by dysregulation of the kallikrein-kinin pathway and excessive bradykinin generation.Although advances in targeted therapies have substantially improved disease control and prognosis, patients with HAE remain vulnerable to procedure-related attacks triggered by …

in, pl (code pays fourni par la source)